REDHILL BIOPHARMA LTD-SP ADR
RDHLNASDAQ🏆 #4051 by market capEarnings Aug 20US Equity
$0.60▲ $0.02 (+3.27%)
Market closed · at close1h—
24h▲ 3.3%
7d▼ 13.0%
14d▼ 13.0%
30d▼ 14.3%
1y▼ 54.9%
🏦Market Cap
$36.49B
Mid Cap
📈Revenue Growth (YoY)
-58.9%
Declining
📊Gross Margin
60.4%
High
💵FCF Margin
—
⚖️P/S Ratio
0.8x
Cheap
Otter Score
45
Weak
📊
Analyst Ratings
Price
$0.6000
Total
10
Raised
0
Lowered
1
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2021-09-15 |
Cantor Fitzgerald | Reiterated | Overweight | 2021-08-31 |
WBB Securities | Downgraded | Strong Buy → Buy | 2021-05-28 |
BTIG | Reiterated | Buy | 2020-09-11 |
H.C. Wainwright | Reiterated | Buy | 2020-03-05 |
Ladenburg Thalmann | Reiterated | Buy | 2018-06-25 |
Nomura | Reiterated | Buy | 2018-01-26 |
Seaport Global | Reiterated | Buy | 2017-10-06 |
Northland Securities | Reiterated | Buy | 2015-09-29 |
Roth Capital | Reiterated | Buy | 2015-06-16 |
One row per institution, most recent rating